Safety and effectiveness assessment of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A meta-analysis

Background: Intravenous immunoglobulin (IVIG) is an established treatment of immune mediated demyelinating neuropathy including Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Recent trials suggest its efficacy in treating relapsing- remitting multiple sclerosis. IVIG...

Descripción completa

Detalles Bibliográficos
Autores principales: Olyaeemanesh, Alireza, Rahmani, Mahbobeh, Goudarzi, Reza, Rahimdel, Abulghasem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898867/
https://www.ncbi.nlm.nih.gov/pubmed/27390706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898867/
https://www.ncbi.nlm.nih.gov/pubmed/27390706

Ejemplares similares